Search results
Results: 227
Number of items: 227
-
Lo-Fo-Wong, D. N., de Haes, H. C., Aaronson, N. K., van Abbema, D. L., Admiraal, J. M., den Boer, M. D., van Hezewijk, M., Immink, M., Kaptein, A. A., Menke-Pluijmers, M. B., Russell, N. S., Schriek, M., Sijtsema, S., van Tienhoven, G., & Sprangers, M. A. (2020). Health care use and remaining needs for support among women with breast cancer in the first 15 months after diagnosis: the role of the GP. Family practice, 37(1), 103-109. https://doi.org/10.1093/fampra/cmz043 -
Husson, O., de Rooij, B. H., Kieffer, J., Oerlemans, S., Mols, F., Aaronson, N. K., van der Graaf, W. T. A., & van de Poll-Franse, L. V. (2020). The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry. The Oncologist, 25(4), e722-e732. https://doi.org/10.1634/theoncologist.2019-0348
-
Giesinger, J. M., Loth, F. L. C., Aaronson, N. K., Arraras, J. I., Caocci, G., Efficace, F., Groenvold, M., van Leeuwen, M., Petersen, M. A., Ramage, J., Tomaszewski, K. A., Young, T., Holzner, B., & EORTC Quality of Life Group (2020). Thresholds for clinical importance were defined for the European Organisation for Research and Treatment of Cancer Computer Adaptive Testing Core—an adaptive measure of core quality of life domains in oncology clinical practice and research. Journal of Clinical Epidemiology, 117, 117-125. https://doi.org/10.1016/j.jclinepi.2019.09.028
-
Giesinger, J. M., Loth, F. L. C., Aaronson, N. K., Arraras, J. I., Caocci, G., Efficace, F., Groenvold, M., van Leeuwen, M., Petersen, M. A., Ramage, J., Tomaszewski, K. A., Young, T., Holzner, B., & EORTC Quality of Life Group (2020). Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research. Journal of Clinical Epidemiology, 118, 1-8. https://doi.org/10.1016/j.jclinepi.2019.10.003
-
Smith, T. G., Dunn, M. E., Levin, K. Y., Tsakraklides, S. P., Mitchell, S. A., van de Poll-Franse, L. V., Ward, K. C., Wiggins, C. L., Wu, X. C., Hurlbert, M., & Aaronson, N. K. (2019). Cancer survivor perspectives on sharing patient-generated health data with central cancer registries. Quality of Life Research, 28(11), 2957-2967. https://doi.org/10.1007/s11136-019-02263-0
-
Sparano, F., Aaronson, N. K., Cottone, F., Piciocchi, A., La Sala, E., Anota, A., Deliu, N., Kieffer, J. M., & Efficace, F. (2019). Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes? Journal of Comparative Effectiveness Research, 8(5), 279-288. https://doi.org/10.2217/cer-2018-0092
-
Sweegers, M. G., Altenburg, T. M., Brug, J., May, A. M., van Vulpen, J. K., Aaronson, N. K., Arbane, G., Bohus, M., Courneya, K. S., Daley, A. J., Galvao, D. A., Garrod, R., Griffith, K. A., Van Harten, W. H., Hayes, S. C., Herrero-Román, F., Kersten, M. J., Lucia, A., McConnachie, A., ... Buffart, L. M. (2019). Effects and moderators of exercise on muscle strength, muscle function and aerobic fitness in patients with cancer: a meta-analysis of individual patient data. British journal of sports medicine, 53(13), Article 812. https://doi.org/10.1136/bjsports-2018-099191
-
Tamminga, S. J., Coenen, P., Paalman, C., de Boer, A. G. E. M., Aaronson, N. K., Oldenburg, H. S. A., van Leeuwen, F. E., van der Beek, A. J., Duijts, S. F. A., & Schaapveld, M. (2019). Factors associated with an adverse work outcome in breast cancer survivors 5–10 years after diagnosis: a cross-sectional study. Journal of Cancer Survivorship, 13(1), 108-116. https://doi.org/10.1007/s11764-018-0731-7
Page 2 of 23